Seres Therapeutics MCRB
NASDAQ MCRB
$2.12 -0.18 (-7.81%)
As of: Oct 22, 2026 · 2:43 PM EDT

Seres Therapeutics (MCRB) Accumulated Expenses (2014 - 2026)

Updated

Seres Therapeutics (MCRB) recorded Accumulated Expenses of $3.74 million in Q2 2026, down 35.6% from $5.81 million a year earlier but up 30.6% from the prior quarter.

Analysis

Seres Therapeutics (MCRB) Accumulated Expenses (2014 - 2026) Analysis & Trends

At the end of FY2025, Seres Therapeutics reported Accumulated Expenses of $3.97 million, down 62.9% from FY2024.

  • Annual Accumulated Expenses has declined for three straight years, with a five-year compound annual growth rate of -22.5% (FY2020 to FY2025).
  • Across earlier years, Accumulated Expenses came in at $10.72 million in FY2024 (-52.4%), $22.51 million in FY2023 (-62.4%), $59.84 million in FY2022 (+32.7%) and $45.09 million in FY2021 (+217.0%).
  • Quarterly Accumulated Expenses has ranged from $2.86 million in Q1 2026 to $86.36 million in Q2 2024 over the past five years.
  • On a year-over-year basis, Accumulated Expenses has declined for eight consecutive quarters, with an average decline of 65.2% over the last eight quarters.
  • Peak year-over-year performance for Accumulated Expenses in the last five years was growth of 332.1% in Q3 2021, against a decline of 93.3% in Q2 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $2.86 million (Q1 2026), $3.97 million (Q4 2025) and $6.38 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,166.06 Bn 1,134.65 Bn 19.71 Bn
2 Johnson & Johnson 647.92 Bn 567.78 Bn 17.30 Bn
3 AbbVie 503.35 Bn 476.46 Bn 12.70 Bn
4 Merck 366.72 Bn 321.10 Bn 12.21 Bn
5 Novartis Ag 303.08 Bn 267.07 Bn 11.24 Bn
6 Astrazeneca 269.05 Bn 242.74 Bn 12.86 Bn
7 Amgen 242.23 Bn 197.63 Bn 7.24 Bn
8 Gilead Sciences 194.93 Bn 169.12 Bn 6.22 Bn
9 Pfizer 172.51 Bn 119.15 Bn 10.94 Bn
10 Seres Therapeutics 20.58 Mn -118.25 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.74 Mn
Mar 31, 2026 2.86 Mn
Dec 31, 2025 3.97 Mn
Sep 30, 2025 6.38 Mn
Jun 30, 2025 5.81 Mn
Mar 31, 2025 6.22 Mn
Dec 31, 2024 10.72 Mn
Sep 30, 2024 17.72 Mn
Jun 30, 2024 86.36 Mn
Mar 31, 2024 76.32 Mn
Dec 31, 2023 22.51 Mn
Sep 30, 2023 54.16 Mn
Jun 30, 2023 55.88 Mn
Mar 31, 2023 44.36 Mn
Dec 31, 2022 59.84 Mn
Sep 30, 2022 59.17 Mn
Jun 30, 2022 56.89 Mn
Mar 31, 2022 48.28 Mn
Dec 31, 2021 45.09 Mn
Sep 30, 2021 48.90 Mn
API Access

Seres Therapeutics Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=MCRB&period=max&api_key=YOUR_API_KEY